The Future of Rocket Pharmaceuticals Inc: Analyzing RCKT

ALXO Stock

In terms of market performance, Rocket Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $26.98 on 07/26/24, and the lowest value was recorded at $4.55 on 04/09/25.

52-week price history of RCKT Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Rocket Pharmaceuticals Inc’s current trading price is -73.42% away from its 52-week high, while its distance from the 52-week low is 57.58%. The stock’s price range during the 52-week period has remained between $4.55 and $26.98. In the Healthcare sector, the company’s shares saw a trading volume of around 5.18 million for the day, which was evidently higher than the average daily volume of 2.2 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Rocket Pharmaceuticals Inc (RCKT) has experienced a quarterly decline of -30.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 764.54M and boasts a workforce of 299 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.08, with a change in price of -5.62. Similarly, Rocket Pharmaceuticals Inc recorded 1,984,127 in trading volume during the last 100 days, posting a change of -43.94%.

Examining RCKT’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RCKT stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.

RCKT Stock Stochastic Average

Rocket Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 39.94%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 61.65%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 48.47% and 43.66%, respectively.

RCKT Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded a decrease of -42.96%. However, over the last six months, the performance has been stronger by -60.30%. The price of RCKT decreased -13.82% over the last 30 days. And in the last five days, it has surged by 36.05%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.